688050 爱博医疗
已收盘 04-08 15:00:00
资讯
新帖
简况
每周股票复盘：爱博医疗（688050）股东毛立平拟减持不超1%股份
证券之星 · 03-22
每周股票复盘：爱博医疗（688050）股东毛立平拟减持不超1%股份
爱博医疗最新公告：股东毛立平拟减持不超1%股份
证券之星 · 03-18
爱博医疗最新公告：股东毛立平拟减持不超1%股份
一笔“熟人买卖”，爱博医疗在押注什么？
蓝鲸财经 · 03-16
一笔“熟人买卖”，爱博医疗在押注什么？
股市必读：爱博医疗（688050）3月4日披露最新机构调研信息
证券之星 · 03-05
股市必读：爱博医疗（688050）3月4日披露最新机构调研信息
爱博医疗：2月24日接受机构调研，American Century、Putnam Investments等多家机构参与
证券之星 · 03-04
爱博医疗：2月24日接受机构调研，American Century、Putnam Investments等多家机构参与
股市必读：爱博医疗发布2025年度业绩快报，盈利2.654亿元
证券之星 · 03-02
股市必读：爱博医疗发布2025年度业绩快报，盈利2.654亿元
每周股票复盘：爱博医疗（688050）2025年净利降31.67%
证券之星 · 03-01
每周股票复盘：爱博医疗（688050）2025年净利降31.67%
爱博医疗（688050）披露2025年度业绩快报，2月27日股价下跌0.1%
证券之星 · 02-27
爱博医疗（688050）披露2025年度业绩快报，2月27日股价下跌0.1%
收购溢价超3倍 爱博医疗押宝运动医学赛道
市场资讯 · 02-27
收购溢价超3倍 爱博医疗押宝运动医学赛道
爱博医疗拟斥资6.83亿元收购某医疗科技公司68.3%股权
美股速递 · 02-25
爱博医疗拟斥资6.83亿元收购某医疗科技公司68.3%股权
爱博医疗最新公告：拟6.83亿元收购德美医疗68.31%股权
中金财经 · 02-25
爱博医疗最新公告：拟6.83亿元收购德美医疗68.31%股权
每周股票复盘：爱博医疗（688050）现溢价15.1%大宗交易
证券之星 · 02-15
每周股票复盘：爱博医疗（688050）现溢价15.1%大宗交易
2月12日爱博医疗现1笔溢价15.1%的大宗交易 合计成交241.5万元
证券之星 · 02-12
2月12日爱博医疗现1笔溢价15.1%的大宗交易 合计成交241.5万元
10亿跨界并购背后：爱博医疗的增长焦虑与整合难题
新浪证券 · 01-22
10亿跨界并购背后：爱博医疗的增长焦虑与整合难题
爱博医疗(688050.SH)拟收购德美医疗不低于51%股权 拓宽医疗健康领域布局
智通财经 · 01-20
爱博医疗(688050.SH)拟收购德美医疗不低于51%股权 拓宽医疗健康领域布局
每周股票复盘：爱博医疗（688050）将召开2025年Q3业绩说明会
证券之星 · 2025-11-23
每周股票复盘：爱博医疗（688050）将召开2025年Q3业绩说明会
爱博医疗（688050）359.36万股限售股将于11月12日解禁，占总股本1.86%
证券之星 · 2025-11-12
爱博医疗（688050）359.36万股限售股将于11月12日解禁，占总股本1.86%
爱博医疗目标价涨幅超70%，荣盛石化、珀莱雅评级被调低
21世纪经济报道 · 2025-11-05
爱博医疗目标价涨幅超70%，荣盛石化、珀莱雅评级被调低
【机构调研记录】格林基金调研潮宏基、爱博医疗等3只个股（附名单）
证券之星 · 2025-11-05
【机构调研记录】格林基金调研潮宏基、爱博医疗等3只个股（附名单）
【机构调研记录】德邦基金调研爱博医疗
证券之星 · 2025-11-05
【机构调研记录】德邦基金调研爱博医疗
加载更多
公司概况
公司名称：
爱博诺德(北京)医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-07-29
主营业务：
爱博诺德(北京)医疗科技股份有限公司的主营业务是眼科医疗器械的自主研发、生产、销售及相关服务。公司的主要产品是人工晶状体、其他手术产品、角膜塑形镜、其他近视防控产品、隐形眼镜、其他视力保健产品。
发行价格：
33.55
{"stockData":{"symbol":"688050","market":"SH","secType":"STK","nameCN":"爱博医疗","latestPrice":52.55,"timestamp":1775631600000,"preClose":51.33,"halted":0,"volume":1383105,"delay":0,"changeRate":0.0238,"floatShares":193000000,"shares":193000000,"eps":1.8665,"marketStatus":"已收盘","change":1.22,"latestTime":"04-08 15:00:00","open":52.28,"high":52.68,"low":51.69,"amount":72573300,"amplitude":0.0193,"askPrice":52.56,"askSize":3,"bidPrice":52.55,"bidSize":1,"shortable":0,"etf":0,"ttmEps":1.8665,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775698200000},"marketStatusCode":5,"adr":0,"adjPreClose":51.33,"symbolType":"stock_kcb","openAndCloseTimeList":[[1775611800000,1775619000000],[1775624400000,1775631600000]],"highLimit":56.46,"lowLimit":46.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":193403175,"isCdr":false,"pbRate":3.62,"roa":"--","peRate":28.154299,"roe":"10.96%","epsLYR":2.05,"committee":0.214815,"marketValue":10163000000,"turnoverRate":0.0072,"status":0,"afterMarket":{"amount":0,"volume":0,"close":52.55,"buyVolume":0,"sellVolume":0,"time":1775633637558,"indexStatus":"已收盘 04-08 15:30:00","preClose":51.33},"floatMarketCap":10163000000},"requestUrl":"/m/hq/s/688050","defaultTab":"news","newsList":[{"id":"2621796514","title":"每周股票复盘：爱博医疗（688050）股东毛立平拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796514","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796514?lang=zh_cn&edition=full","pubTime":"2026-03-22 01:52","pubTimestamp":1774115533,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，爱博医疗报收于51.81元，较上周的55.06元下跌5.9%。本周关注点公司公告汇总：股东毛立平拟通过大宗交易减持不超过公司总股本的1%。公司公告汇总688050爱博医疗 股东减持股份计划公告截至公告披露日，股东毛立平持有爱博医疗5,604,413股，占总股本2.90%，与其一致行动人白莹合计持有11,304,459股，占总股本5.85%。毛立平计划通过大宗交易方式减持不超过1,934,000股，即不超过公司总股本的1%，减持期间为2026年4月10日至2026年7月9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688050","BK0251","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620308122","title":"爱博医疗最新公告：股东毛立平拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2620308122","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620308122?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:11","pubTimestamp":1773832267,"startTime":"0","endTime":"0","summary":"爱博医疗公告称，股东毛立平计划通过大宗交易方式减持不超过193.40万股公司股份，占公司总股本的1%。减持原因为个人资金需求，减持期间为公告披露之日起15个交易日后的3个月内（2026年4月10日至2026年7月9日）。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800034303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","BK0251","688050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619807134","title":"一笔“熟人买卖”，爱博医疗在押注什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2619807134","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619807134?lang=zh_cn&edition=full","pubTime":"2026-03-16 10:31","pubTimestamp":1773628280,"startTime":"0","endTime":"0","summary":"文｜《投资者网》蔡俊近期，爱博医疗再度出手收购。“熟人买卖”根据公告，公司拟使用并购贷款及自有资金收购德美医疗68.31%股权，交易对价为6.83亿元。一方认为，公司收购的存在较高溢价。另一方表示，本次对价较2021年标的E轮有明显降幅。同时，本次收购也未被认定关联交易。换言之，消费医疗的押注开始成了一种负担。正面，公司的隐形眼镜业务收入占比在增长，并保持增速。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1773405800856505153","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU2460026573.USD","BK0251","688050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617550236","title":"股市必读：爱博医疗（688050）3月4日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2617550236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617550236?lang=zh_cn&edition=full","pubTime":"2026-03-05 01:45","pubTimestamp":1772646315,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘，爱博医疗报收于56.75元，下跌0.73%，换手率0.95%，成交量1.84万手，成交额1.05亿元。来自机构调研要点：公司人工晶状体产品为中国市场市占率第一，高端产品如龙晶PR推动收入小幅增长。来自机构调研要点：龙晶PR因材料薄、光学设计优，可降低夜间眩光，获临床高度认可。来自机构调研要点：普诺瞳OK镜跻身国内角膜塑形镜市场前三，构建多元化近视防控产品矩阵。该产品目前仍处于市场推广阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500000936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688050","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616153190","title":"爱博医疗：2月24日接受机构调研，American Century、Putnam Investments等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2616153190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616153190?lang=zh_cn&edition=full","pubTime":"2026-03-04 19:01","pubTimestamp":1772622079,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年3月4日爱博医疗发布公告称公司于2026年2月24日接受机构调研，American Century、Putnam Investments、Spectrum Entrepreneurial Ownership、Springs Capital、T Rowe Price、UG Investment、1832 Asset Management LP、Artisan Partners Asset Management Inc、Balyasny Asset Management、Capital Strategy Research、Fidelity、Goldman Sachs、Lazard Group LLC、MIV Asset Management、Panjing Investment参与。PR 有晶体眼人工晶状体等高端产品增长迅速，推动公司人工晶状体板块收入保持小幅增长。PR 产品已获得临床医生与患者的高度认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400034029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","BK0251","688050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616791068","title":"股市必读：爱博医疗发布2025年度业绩快报，盈利2.654亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616791068","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616791068?lang=zh_cn&edition=full","pubTime":"2026-03-02 04:00","pubTimestamp":1772395237,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，爱博医疗报收于62.34元，下跌0.1%，换手率1.01%，成交量1.96万手，成交额1.22亿元。业绩披露要点业绩快报爱博医疗近日即将发布2025年年报，根据2月27日发布的业绩快报，归属净利润盈利2.654亿元，同比减少31.67%。公司公告汇总688050爱博医疗 2025年度业绩快报爱博诺德（北京）医疗科技股份有限公司发布2025年度业绩快报，营业总收入148,270.27万元，同比增长5.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200001829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","688050","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616845741","title":"每周股票复盘：爱博医疗（688050）2025年净利降31.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845741?lang=zh_cn&edition=full","pubTime":"2026-03-01 03:11","pubTimestamp":1772305869,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，爱博医疗报收于62.34元，较上周的59.5元上涨4.77%。本周，爱博医疗2月26日盘中最高价报63.54元。业绩披露要点爱博医疗预计发布2025年年报，根据业绩快报，归属净利润为2.654亿元，同比减少31.67%。营业总收入达148,270.27万元，同比增长5.15%。公司公告汇总爱博诺德（北京）医疗科技股份有限公司拟以并购贷款及自有资金收购德美联合（重庆）医疗科技有限公司68.31%股权，交易对价为68,300.46万元。交易完成后，德美医疗将纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688050","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614850774","title":"爱博医疗（688050）披露2025年度业绩快报，2月27日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614850774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614850774?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:40","pubTimestamp":1772206824,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，爱博医疗报收于62.34元，较前一交易日下跌0.1%，最新总市值为120.57亿元。该股当日开盘62.18元，最高62.4元，最低61.83元，成交额达1.22亿元，换手率为1.01%。近日，爱博诺德（北京）医疗科技股份有限公司发布2025年度业绩快报，营业总收入148,270.27万元，同比增长5.15%。归属于母公司所有者的净利润26,541.48万元，同比减少31.67%。总资产388,198.73万元，较期初增长11.01%；归属于母公司的所有者权益278,597.73万元，增长15.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700043507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688050","LU2460026573.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614999077","title":"收购溢价超3倍 爱博医疗押宝运动医学赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2614999077","media":"市场资讯","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614999077?lang=zh_cn&edition=full","pubTime":"2026-02-27 00:58","pubTimestamp":1772125080,"startTime":"0","endTime":"0","summary":" 眼科器械龙头爱博医疗拟通过并购切入运动医学领域。在前次披露投资意向一个月后，爱博医疗于2月26日发布具体收购方案，拟以6.83亿元收购德美联合（重庆）医疗科技有限公司68.31%股权，交易作价较净资产账面值溢价超3倍。爱博医疗相关负责人表示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-27/doc-inhpemqa4208131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688050","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189806936","title":"爱博医疗拟斥资6.83亿元收购某医疗科技公司68.3%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1189806936","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189806936?lang=zh_cn&edition=full","pubTime":"2026-02-25 20:21","pubTimestamp":1772022100,"startTime":"0","endTime":"0","summary":"爱博医疗宣布，公司计划以6.83亿元人民币收购一家医疗科技企业68.3%的股权。此次交易旨在拓展公司业务版图，强化其在医疗技术领域的综合竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688050","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614819050","title":"爱博医疗最新公告：拟6.83亿元收购德美医疗68.31%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2614819050","media":"中金财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614819050?lang=zh_cn&edition=full","pubTime":"2026-02-25 20:05","pubTimestamp":1772021126,"startTime":"0","endTime":"0","summary":"爱博医疗(688050.SH)公告称，公司拟使用并购贷款及自有资金收购德美联合(重庆)医疗科技有限公司68.31%股权，交易对价为6.83亿元。标的公司已入选第四批国家高值医用耗材集采A组，位列行业第一梯队；拥有丰富临床专家资源，销售网络覆盖全国及东南亚、拉丁美洲、中东、欧洲等海外区域，在产品/技术研发、生产制造、境内外销售渠道等方面与公司存在一定的协同性。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260225/32027110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159891","BK0251","LU2460026573.USD","688050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611680145","title":"每周股票复盘：爱博医疗（688050）现溢价15.1%大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2611680145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611680145?lang=zh_cn&edition=full","pubTime":"2026-02-15 02:18","pubTimestamp":1771093092,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，爱博医疗报收于59.5元，较上周的60.26元下跌1.26%。本周，爱博医疗2月9日盘中最高价报61.32元。爱博医疗当前最新总市值115.07亿元，在医疗器械板块市值排名31/129，在两市A股市值排名1804/5189。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688050","BK0251","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610915949","title":"2月12日爱博医疗现1笔溢价15.1%的大宗交易 合计成交241.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610915949","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610915949?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:42","pubTimestamp":1770889355,"startTime":"0","endTime":"0","summary":"近三个月该股共发生1笔大宗交易，合计成交350.0手，溢价成交1笔。该股在过去半年内已有共计359.36万股限售解禁股上市，占公司总股本的1.86%。截至2026年2月12日收盘，爱博医疗报收于59.95元，下跌0.45%，换手率0.86%，成交量1.66万手，成交额9957.96万元。该股近半年内有股东持股变动，合计净减持215.87万股，股东增减持明细如下表：该股最近90天内共有5家机构给出评级，买入评级2家，增持评级3家；过去90天内机构目标均价为80.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200029031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688050","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605466672","title":"10亿跨界并购背后：爱博医疗的增长焦虑与整合难题","url":"https://stock-news.laohu8.com/highlight/detail?id=2605466672","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605466672?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:36","pubTimestamp":1769070960,"startTime":"0","endTime":"0","summary":"眼科龙头爱博医疗正试图通过一场跨界并购，寻找新的增长故事。近日，公司宣布拟以不超过10亿元估值收购运动医学企业德美医疗不低于51%股权，切入以关节与肌肉为核心的运动医学赛道。然而，在主业增长乏力、股价持续低迷的背景下，这场并购能否真正带来协同效应，仍面临估值、对赌与整合三重考验。 对爱博医疗而言，这场跨界并购既是寻找第二增长曲线的战略尝试，也是一场充满变数的赌博。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-22/doc-inhiepsr4563589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688050","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604415115","title":"爱博医疗(688050.SH)拟收购德美医疗不低于51%股权 拓宽医疗健康领域布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2604415115","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604415115?lang=zh_cn&edition=full","pubTime":"2026-01-20 21:26","pubTimestamp":1768915610,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱博医疗 发布公告，公司于2026年1月20日与德美联合(重庆)医疗科技有限公司及德美医疗创始人、第一大股东、董事长、总经理兼法定代表人黎建波签署《投资意向书》，公司拟通过并购贷款及自有资金出资方式收购标的公司不低于51%的股权并取得标的公司的控制权。通过本次收购标的公司控股权，公司拓宽医疗健康领域布局，在研发、生产制造、销售渠道等方面与标的公司协同，进一步提升公司业绩与股东回报水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XBI","XLV","688050","LABU","159760","BK4588","159891","BK4581","BK4585","BK0251","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585106969","title":"每周股票复盘：爱博医疗（688050）将召开2025年Q3业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585106969","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585106969?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:46","pubTimestamp":1763844371,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，爱博医疗报收于60.3元，较上周的64.83元下跌6.99%。本周，爱博医疗11月17日盘中最高价报65.0元。11月21日盘中最低价报59.63元，股价触及近一年最低点。爱博医疗当前最新总市值116.62亿元，在医疗器械板块市值排名25/126，在两市A股市值排名1552/5167。投资者可于2025年11月21日至11月27日16:00前通过上证路演中心或公司邮箱提交问题。说明会结束后可通过上证路演中心查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","688050","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582316464","title":"爱博医疗（688050）359.36万股限售股将于11月12日解禁，占总股本1.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582316464","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582316464?lang=zh_cn&edition=full","pubTime":"2025-11-12 08:05","pubTimestamp":1762905924,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，爱博医疗于11月12日将有359.36万股限售股份解禁，为公司定向增发机构配售股份，占公司总股本1.86%。本次解禁后，公司已无限售股份。爱博医疗主营业务：专注于眼科医疗器械的自主研发、生产、销售及相关服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200005049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","688050","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581718050","title":"爱博医疗目标价涨幅超70%，荣盛石化、珀莱雅评级被调低","url":"https://stock-news.laohu8.com/highlight/detail?id=2581718050","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581718050?lang=zh_cn&edition=full","pubTime":"2025-11-05 10:32","pubTimestamp":1762309920,"startTime":"0","endTime":"0","summary":"南财投研通数据显示，11月4日，券商给予上市公司目标价共67次，按最新收盘价计算，目标价涨幅排名居前的公司有爱博医疗、凌云股份、豪悦护理，目标价涨幅分别为70.94%、54.33%、51.42%，分 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20251105/c672255919.shtml","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251105/c672255919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["002493","688050","603605"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581799450","title":"【机构调研记录】格林基金调研潮宏基、爱博医疗等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2581799450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581799450?lang=zh_cn&edition=full","pubTime":"2025-11-05 08:06","pubTimestamp":1762301189,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月4日披露的机构调研信息，格林基金近期对3家上市公司进行了调研，相关名单如下：1）潮宏基 调研纪要：公司通过产品创新、运营能力提升及加盟扩张推动收入增长与盈利能力改善。3）心脉医疗 调研纪要：2025年第三季度，公司实现营业收入3亿元、归母净利润1.14亿元，剔除政府补贴及其他投资收益影响后净利润同比增长60%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500005019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002345","BK0127","BK0262","688050","LU2460026573.USD","BK0107","BK0070","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581799115","title":"【机构调研记录】德邦基金调研爱博医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2581799115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581799115?lang=zh_cn&edition=full","pubTime":"2025-11-05 08:06","pubTimestamp":1762301177,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月4日披露的机构调研信息，德邦基金近期对1家上市公司进行了调研，相关名单如下：1）爱博医疗 个股亮点：公司已自主开发普诺瞳 AI数字验配系统。德邦基金成立于2012年，截至目前，资产管理规模605.16亿元，排名81/211；资产管理规模494.4亿元，排名77/211；管理公募基金数70只，排名84/211；旗下公募基金经理16人，排名84/211。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500005005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688050","LU2460026573.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775659441514,"stockEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0988},{"period":"3month","weight":-0.1886},{"period":"6month","weight":-0.3037},{"period":"1year","weight":-0.4927},{"period":"ytd","weight":-0.1538}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0567},{"period":"3month","weight":-0.0479},{"period":"6month","weight":-0.0111},{"period":"1year","weight":0.2563},{"period":"ytd","weight":-0.0198}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱博诺德(北京)医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"17214人(较上一季度增加11.72%)","perCapita":"11235股","listingDate":"2020-07-29","address":"北京市昌平区科技园区兴昌路9号","registeredCapital":"19340万元","survey":" 爱博诺德(北京)医疗科技股份有限公司的主营业务是眼科医疗器械的自主研发、生产、销售及相关服务。公司的主要产品是人工晶状体、其他手术产品、角膜塑形镜、其他近视防控产品、隐形眼镜、其他视力保健产品。","listedPrice":33.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱博医疗(688050)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱博医疗(688050)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱博医疗,688050,爱博医疗股票,爱博医疗股票老虎,爱博医疗股票老虎国际,爱博医疗行情,爱博医疗股票行情,爱博医疗股价,爱博医疗股市,爱博医疗股票价格,爱博医疗股票交易,爱博医疗股票购买,爱博医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱博医疗(688050)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱博医疗(688050)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}